NO
NOVA.DU Novo Nordisk A/S
- EUR
- Market cap
- -
- P/E
- 10.2x
- P/B
- 5.32x
- ROE
- -
- Dividend yield
- 1.17%
- Fundamental score
- -
Is NOVA.DU undervalued?
Graham numberThe Graham number of Novo Nordisk A/S cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Novo Nordisk A/S fundamental analysis
No fundamental analysis for Novo Nordisk A/S yet.
Novo Nordisk A/S stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Novo Nordisk A/S are not available yet.
Novo Nordisk A/S dividends
Novo Nordisk A/S has not paid dividends in the last 1 fiscal years.
Last stock split: 2:1 on Sep 20, 2023.
Who owns Novo Nordisk A/S
Ownership data of Novo Nordisk A/S is not available yet.
Novo Nordisk A/S company profile
- Company name
- Novo Nordisk A/S
- Ticker
- NOVA.DU
- Exchange
- Dusseldorf Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -